Investing

Business

Robert Half Stock Soars 28% After Truist Bullish Call, Defying Earnings Slump

Shares of staffing giant Robert Half International surged nearly 28% in a single session, propelled by a significant price target increase from Truist Securities. The rally comes despite the company reporting a sharp decline in annual profits, highlighting a stark divergence between analyst confidence and recent financial performance.

Jan 31, 2026

Business

Federated Hermes: A 38% Surge Leaves Investors Questioning Value

Despite a stellar 38% gain over the past year, analysis suggests Federated Hermes (NYSE: FHI) shares may still be trading at a discount to their intrinsic value, presenting a potential opportunity in the capital markets sector.

Jan 31, 2026

Business

Definium Therapeutics Bolsters Board with Commercial Veteran Roger Adsett Ahead of Pivotal Trials

Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.

Jan 31, 2026

Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Jan 31, 2026

Business

Johnson & Johnson Poised to Join $100 Billion Sales Club, Defying Industry Headwinds

The healthcare behemoth's robust 2025 results and 2026 guidance signal a landmark year ahead, as it navigates patent expirations and pricing pressures while maintaining its coveted dividend king status.

Jan 31, 2026

Business

Robinhood's Pivot: From Meme Stocks to Government Mandates and Tokenized Markets Amid Valuation Scrutiny

Robinhood Markets is navigating a transformative phase, reportedly in talks to manage a potential federal 'Trump account' program for minors while simultaneously expanding into tokenized equities and prediction markets. This strategic shift raises critical questions about its regulatory footprint, business model evolution, and long-term valuation.

Jan 31, 2026

Business

Simpson Manufacturing Expands with New Tennessee Plant Amid Investor Scrutiny on Growth Trajectory

Simpson Manufacturing Co. (NYSE: SSD) has inaugurated a new production facility in Gallatin, Tennessee, marking a strategic step in its operational expansion. The move comes as investors assess the company's valuation following a period of strong stock performance.

Jan 31, 2026

Business

RH Stock: A Deep Value Play or Value Trap? Analysts Clash After 53% Plunge

RH shares have cratered over 50% in the past year, battered by concerns over high-end consumer spending. While a key valuation model suggests the luxury home furnishing retailer is deeply undervalued, its premium earnings multiple tells a conflicting story, leaving investors to question if this is a buying opportunity or a sign of deeper troubles.

Jan 31, 2026

Business

FICO's Recent Pullback: A Buying Opportunity or a Sign of Overvaluation?

Fair Isaac Corporation (FICO) shares have retreated from recent highs, prompting investors to reassess the valuation of the credit-scoring giant. With the stock down over 13% in the past month, we examine whether the dip presents a strategic entry point or confirms concerns that the rally has run its course.

Jan 31, 2026

Business

CN Rail Boosts Shareholder Returns Amid Stock Slump, Unveils New Buyback and Dividend Hike

Canadian National Railway is ramping up capital returns to shareholders through a significant new share repurchase program and a dividend increase, as the rail giant seeks to reassure investors following a period of underperformance in its stock price.

Jan 31, 2026

Business

Day One Biopharmaceuticals: Surging Momentum Raises Valuation Questions Amid High-Stakes Pipeline

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) have surged over 50% in the last three months, reigniting debate over its fair value and the risks tied to its lead drug OJEMDA and a pivotal upcoming data readout.

Jan 31, 2026

Business

Bloom Energy Powers Up: Major Deals Fuel AI Data Center Ambitions and Investor Rethink

Bloom Energy's landmark $2.65 billion power agreement and a potential $5 billion infrastructure partnership signal a strategic pivot to become a cornerstone provider for the energy-hungry AI data center industry, prompting a fresh look at its long-term valuation.

Jan 31, 2026

Business

Walmart Boosts Pharmacy Pay, Adds 3,000 Leadership Roles in Major Workforce Investment

In a significant move to bolster its healthcare services and retain staff, Walmart is creating thousands of new leadership positions and raising wages for pharmacy technicians across its U.S. stores.

Jan 31, 2026

Business

Andreessen Horowitz Partner Departs Following Pause of Flagship Diversity Initiative

Kofi Ampadu, the partner who led a16z's Talent x Opportunity fund, has left the firm months after the program was paused indefinitely, signaling a potential retreat from structured DEI efforts in venture capital.

Jan 31, 2026

Business

Imperial Oil Caps 2025 with Record Cash Flow and Major Dividend Hike, Weathers Operational Headwinds

Imperial Oil Ltd. reported robust fourth-quarter results, generating nearly $1.4 billion in free cash flow and announcing its largest-ever nominal dividend increase. Despite weather disruptions at its Kearl oil sands operation, the company highlighted record annual production and a disciplined capital return strategy that saw $4.6 billion returned to shareholders in 2025.

Jan 31, 2026

Business

Private Equity and Institutions Bear Brunt as BCI Minerals Shares Tumble 7.8%

Last week's sharp sell-off in BCI Minerals wiped AU$103 million from its market value, with private companies and institutional investors, who collectively control nearly 70% of the stock, feeling the deepest pain. The drop raises questions about shareholder influence and the company's near-term outlook.

Jan 31, 2026

Business

Analysts Revise Outlook: What's Driving the New Price Target for Illinois Tool Works (ITW)

A revised price target for industrial conglomerate Illinois Tool Works has refocused investor attention, prompting a fresh assessment of the company's strategic positioning and market sentiment.

Jan 31, 2026

Business

Blue Foundry Bancorp Shareholders Greenlight Merger with Fulton Financial

Shareholders of Blue Foundry Bancorp have voted decisively to approve the company's merger agreement with Fulton Financial Corporation, clearing a critical hurdle in the creation of a stronger regional banking entity.

Jan 31, 2026

Business

Financial Guru Dave Ramsey Advises Young Woman to Decline Father's Unusual 'Investment' Request

A 24-year-old's father asked her to pay the premiums on his life insurance policy, framing it as an investment for her future. Personal finance expert Dave Ramsey and his co-host Ken Coleman weighed in on the emotional and financial pitfalls of such an arrangement.

Jan 30, 2026

Business

Bessent Defends 'Trump Accounts' as 'Rainy Day' Savings, Dismisses Wealth Gap Critics as Major Banks Join Initiative

Treasury Secretary Scott Bessent champions the new 'Trump Accounts' as a crucial savings tool for future generations, brushing aside concerns they may exacerbate inequality. The program gains momentum with backing from JPMorgan, Bank of America, and high-profile philanthropists.

Jan 30, 2026